Latest Breaking News On - Centric advisors - Page 17 : comparemela.com

Sarepta Therapeutics (NASDAQ:SRPT) Now Covered by Analysts at StockNews com

StockNews.com began coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research report report published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Other equities research analysts have also issued reports about the company. Morgan Stanley restated an overweight rating and issued a $183.00 price target […]

Hans lennart rudolf wigzellJpmorgan chase coSarepta therapeutics incFirst horizon advisors incKb financial partnersIndustrial alliance investment management incCantor fitzgeraldMorgan stanleySumitomo mitsui financial groupAlphacentric advisorsSarepta therapeuticsFree reportMitsui financial groupModerate buyGet free reportDirector michael andrew chambers

Insider Selling: DocGo Inc (NASDAQ:DCGO) Insider Sells 50,000 Shares of Stock

Insider Selling: DocGo Inc (NASDAQ:DCGO) Insider Sells 50,000 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAdriaan stephanus oberholzerStifel nicolausNeedham companyCorecap advisorsCannell capitalP aw capital corpSecurities exchange commissionDocgo incAw capital corpCantor fitzgeraldAlphacentric advisorsGet free reportExchange commissionStephanus oberholzer

FY2023 Earnings Estimate for Draganfly Inc (NASDAQ:DPRO) Issued By HC Wainwright

FY2023 Earnings Estimate for Draganfly Inc (NASDAQ:DPRO) Issued By HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Virtu financialAlphacentric advisorsAlliance wealth advisorsCitadel advisorsDraganfly incFree reportCentric advisorsStreet groupGet free reportDraganfly daily

DraftKings (NASDAQ:DKNG) Given New $34 00 Price Target at Argus

DraftKings (NASDAQ:DKNG – Free Report) had its price target upped by Argus from $30.00 to $34.00 in a report released on Thursday, Marketbeat.com reports. The firm currently has a buy rating on the stock. Other equities research analysts have also recently issued research reports about the company. Guggenheim boosted their price objective on DraftKings from […]

Roth mkmJason robinsMatthew kalishAlphacentric advisorsHarvest fund management coSecurities exchange commissionJpmorgan chase coBarrett company incDraftkings incRaleigh capital management incWealthplan partnersDraftkings company profileFree reportModerate buyExchange commissionCapital management

DraftKings (NASDAQ:DKNG) PT Raised to $42 00

DraftKings (NASDAQ:DKNG – Free Report) had its price objective hoisted by Jefferies Financial Group from $38.00 to $42.00 in a research report report published on Sunday morning, MarketBeat Ratings reports. They currently have a buy rating on the stock. Several other research firms also recently weighed in on DKNG. Bank of America raised shares of […]

United statesMatthew kalishErik bradburyPiper sandlerStifel nicolausSecurities exchange commissionDraftkings incWealthplan partnersJefferies financial groupBarrett company incAlphacentric advisorsDraftkings company profileRaleigh capital management incHarvest fund management coFree reportMarketbeat ratings